Companies
Wood Centre for Innovation
Bioarchitech
Ceo - Co-founder/CEO: Kevin Maskell
Sector - Healthcare
Bioarchitech is developing a treatment to enable the body’s own immune system to kill cancer cells. To do this, the team is engineering a virus (a strain of the smallpox vaccine) with unique genes that will encode antibody-like immunotherapy molecules to stimulate an immune response to cancer cells.
DJS Antibodies
Ceo - Co-founder/Research Director: Joe Illingworth
Sector - Healthcare
DJS is developing novel therapeutics to treat chronic inflammatory diseases. Their lead programme is looking to revolutionise the treatment of high mortality fibrotic diseases, such as Idiopathic Pulmonary Fibrosis (IPF). They have produced the first ever antibody, DJS-002 which targets the disease.
Helio Display Materials
Ceo - VP Engineering: Dr Valerie Berryman-Bousquet
Sector - Display technologies
A joint Oxford and Cambridge spinout, Helio is delivering the next generation of light-emitting materials and technologies for displays.
Jack Fertility
Ceo - Co-founder/CEO: Lily Elsner
Sector - Healthcare
The only mail-in sperm testing company in the UK, start-up Jack Fertility aims to change the conversation about fertility and address a gender imbalance in the lack of fertility testing and support available to men.
Lumai
Ceo - CEO: Tim Weil
Sector - Optical Computing
Lumai is developing high performance 3D optical computers. Its technology aims to revolutionise efficiency in multiple industries and unlock the potential of the next generation of AI.
PicturaBio
Ceo - CEO: Alex Batchelor
Sector - Machine Learning
As a result of six years of research in the University of Oxford’s Department of Physics, PicturaBio is working on a universal testing platform to identify pathogens using single-molecule fluorescent microscopy and machine learning.
RedShiftBio
Ceo - CEO: Tom O’Lenic
Sector - Healthcare
RedShiftBio provides analytical instrumentation for the research, development and manufacturing of protein therapeutic drugs.
Samsara Therapeutics
Ceo - Executive Chair: Meenu Chhabra Karson
Sector - Healthcare
Using its LysoSeeker drug discovery platform, Samsara is developing autophagy-directed therapies to fight currently incurable neurodegenerative diseases such as Parkinson’s and Amytotrophic Lateral Sclerosis (ALS).
Spintex
Ceo - Co-Founder/CEO: Alex Greenhalgh
Sector - Textiles
Using a spider-inspired process, Spintex is artificially spinning silk that can be used in sustainable fashion, advanced technical textiles, including lightweight composites for aerospace and automotive industries and biocompatible medical textiles.
